Company · CIK 0001612042 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Ascendis Pharma A/S · ASND
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 SForm 4 → | Sep 9, 5:04 pm EDT | Mads BodenhoffSVP & PAO | 3,000 | $270.19 | $810,570 | 0 | −100% | |
| Sep 8, 2026 MForm 4 → | Sep 9, 5:04 pm EDT | Mads BodenhoffSVP & PAO | 3,000 | $110.00 | $330,000 | 3,000 | — | |
| Sep 2, 2026 SForm 4 → | Sep 3, 4:09 pm EDT | Lars HoltugDirector | 236 | $264.13 | $62,335 | 4,000 | −5.57% | |
| Aug 14, 2026 PForm 4 → | Aug 18, 9:02 pm EDT | Jean Jacques BienaimeDirector | 2,000 | $246.33 | $492,654 | 2,900 | +222% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 MForm 4 → | Sep 9, 5:04 pm EDT | Mads BodenhoffSVP & PAO | 3,000 | — | — | 687 | — |